Richard Daniell - Aug 12, 2024 Form 4 Insider Report for TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA)

Role
Exec. VP, European Commercial
Signature
/s/ Dov Bergwerk as attorney-in-fact for Richard Daniell
Stock symbol
TEVA
Transactions as of
Aug 12, 2024
Transactions value $
-$1,711,447
Form type
4
Date filed
8/13/2024, 04:09 PM
Previous filing
Mar 7, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TEVA Ordinary Shares Sale -$1.71M -98.9K -100% $17.30 0 Aug 12, 2024 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.25 to $17.34, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price.